Schedule 13D ownership disclosure

Gossamer Bio Inc

Common Stock, $0.0001 par value per share · CUSIP: 38341P102

Event date: 2026-02-23

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Growth Equity Opportunities 18 VGE, LLCReported CIK 0001917895

    Shares: 4,065,134.00 · Class: 1.7%

  • NEA 18 Venture Growth Equity, L.P.Reported CIK 0001880239

    Shares: 4,065,134.00 · Class: 1.7%

  • NEA Partners 18 VGE, L.P.Reported CIK 0001898446

    Shares: 4,065,134.00 · Class: 1.7%

  • NEA 18 VGE GP, LLCReported CIK 0001898598

    Shares: 4,065,134.00 · Class: 1.7%

  • Ali BehbahaniReported CIK 0001613867

    Shares: 4,065,134.00 · Class: 1.7%

  • Carmen ChangReported CIK 0001746342

    Shares: 4,065,134.00 · Class: 1.7%

  • Anthony A. Florence, Jr.Reported CIK 0001559827

    Shares: 4,065,134.00 · Class: 1.7%

  • Mohamad H. MakhzoumiReported CIK 0001630226

    Shares: 4,065,134.00 · Class: 1.7%

  • Edward T. MathersReported CIK 0001328625

    Shares: 4,065,134.00 · Class: 1.7%

  • Scott D. SandellReported CIK 0001237289

    Shares: 4,065,134.00 · Class: 1.7%

  • Paul WalkerReported CIK 0001553150

    Shares: 4,065,134.00 · Class: 1.7%

  • Rick YangReported CIK 0001851328

    Shares: 4,065,134.00 · Class: 1.7%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001072613-26-000213
Form type
SCHEDULE 13D/A
Filer
Gossamer Bio, Inc.
CIK
CIK 1728117
Filed
Feb 24, 2026
Reporting period
Feb 23, 2026
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub